Abstract
Heptahelical opioid receptors utilize Gi proteins to regulate a multitude of effectors including the classical adenylyl cyclases and the more recently discovered mitogen-activated protein kinases (MAPKs). The c-Jun NH2-terminal kinases (JNKs) belong to one of three subgroups of MAPKs. In NG108-15 neuroblastoma x glioma hybrid cells that endogenously express δ-opioid receptors, δ-agonist dose-dependently stimulated JNK activity in a pertussis toxin-sensitive manner. By using COS-7 cells transiently transfected with the cDNAs of δ-opioid receptor and hemagglutinin (HA)-tagged JNK, we delineated the signaling components involved in this pathway. Sequestration of Gβγ subunits by transducin suppressed the opioid-induced JNK activity. The possible involvement of the small GTPases was also examined. Expression of dominant negative mutants of Rac and Cdc42 blocked the opioid-induced JNK activation, and a partial inhibition was observed in the presence of the dominant negative mutant of Ras. In contrast, the dominant negative mutant of Rho did not affect the opioid-induced JNK activation. In addition, the receptor-mediated JNK activation was dependent on Src family tyrosine kinases, but independent of phosphatidylinositol-3 kinase and EGF receptor tyrosine kinases. Collectively, these results demonstrate functional regulation of JNK by the δ-opioid receptor, and this pathway requires Gβγ, Src kinases and the small GTPases Rac and Cdc42.
| Original language | English |
|---|---|
| Pages (from-to) | 503-513 |
| Number of pages | 11 |
| Journal | Journal of Neurochemistry |
| Volume | 84 |
| Issue number | 3 |
| DOIs | |
| Publication status | Published - Feb 2003 |
Keywords
- EGF receptor
- Gβγ
- JNK
- P13K
- Small GTPases
- Src
- δ-opioid receptor